where to shoot retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam What to Know About Retatrutide

The FDA briefing documents reflect this pattern of front-loaded side effects that resolve with continued use

Pushing through with modified food choices pays dividends

While medications like semaglutide focus on a single pathway that helps control appetite and blood sugar, tirzepatide activates two complementary pathways at the same time

The psychological effects of testosterone matter as well

By week eight, those issues faded almost completely

Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1) , GIP (Glucose-Dependent Insulinotropic Polypeptide) , and Glucagon receptors